Advocacy intelligence hub — real-time data for patient organizations
Hôpital Necker-Enfants Malades
Hôpital Necker-Enfants Malades
Amylyx Pharmaceuticals Inc. — PHASE2
University of Birmingham — PHASE2
Washington University School of Medicine
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Tamara Hershey, PhD
Washington University Medical School
Camille Bedrosian, MD, MD
Amylyx Pharmaceuticals
📍 CAMBRIDGE, MA
Timothy Barrett, PhD, MB, BS
University of Birmingham
Christophe Orssaud, MD
UF Ophthalmology HEGP
Fumihiko Urano, MD, MD
Washington University School of Medicine
📍 SAINT LOUIS, MO
Tamara G Hershey, PhD
Washington University Medical School